Skip to Main Content

Paper Details

Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance).
Clin Cancer Res
8
2022
Author NameAffiliation
Phillip G FebboIllumina Inc.
Himisha BeltranHarvard Cancer Center
Himisha BeltranHarvard Cancer Center
Eric J SmallUniversity of California san francisco
Michael J MorrisMemorial Sloan Kettering Cancer Center
  • 1 - 5

Datasets

Release 1.2